Effentora

Effentora is a buccal fentanyl tablet used for managing breakthrough pain in adults already on opioid therapy. This fast-acting medication is designed for oral mucosal use.

Effentora is primarily used for the treatment of breakthrough pain in adults who are already receiving opioid therapy for chronic pain. It is designed to be placed between the cheek and gum, where it dissolves to deliver rapid pain relief. This medication is not intended for initial pain management but rather for sudden, severe pain that occurs despite regular opioid use.

Common effects of Effentora may include drowsiness, dizziness, nausea, and headache. Some users may experience constipation or dry mouth. These effects can vary in intensity and duration depending on individual factors.

Effentora should be handled with care to avoid accidental exposure. It is important to follow the prescribed usage instructions to minimize the risk of side effects. This medication should be stored securely to prevent misuse or accidental ingestion, especially by children or pets.

Effentora may interact with other medications, including other opioids, sedatives, and certain antidepressants. Alcohol should be avoided while using Effentora, as it can enhance the sedative effects. Always consult a healthcare provider before combining Effentora with other medications.